ILA island pharmaceuticals limited

Ann: Total of $2.72m raised from ILAO options, page-9

  1. 124 Posts.
    lightbulb Created with Sketch. 38
    This is a repurposed drug that has safety data available from previous Phase 3 trials for other indications. There is no reason to have another phase 3 data tria for safety data. It would be almost impossible to design a treatment trial for a mosquito-transmitted virus like Dengue as its onset and diagnosis are so uncertain even in endemic areas. You cannot ethically just give people standard Dengue Fever for a trial. Surely a phase 3 trial would use the US Army's attenuated Dengue Virus strain again and repeat the Phase 2b study with a larger number of cases. The US Army would most likely fund and run the trial.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
15.0¢
Change
-0.020(11.8%)
Mkt cap ! $37.08M
Open High Low Value Volume
16.0¢ 16.0¢ 15.0¢ $144.2K 944.4K

Buyers (Bids)

No. Vol. Price($)
4 188326 15.0¢
 

Sellers (Offers)

Price($) Vol. No.
15.5¢ 10000 1
View Market Depth
Last trade - 16.10pm 25/07/2025 (20 minute delay) ?
ILA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.